Morgan Stanley Downgrades Merck (MRK) to Equalweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Oil rally pressures S&P, Nasdaq; Microsoft, Salesforce buoy Dow
- Oil prices rise 2% as attacks on Saudi Arabia overshadow Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts MRK Hot Sheet
Price: $145.28 -0.22%
Rating Summary:
24 Buy, 7 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 19 | Down: 20 | New: 46
Rating Summary:
24 Buy, 7 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 19 | Down: 20 | New: 46
Join SI Premium – FREE
Morgan Stanley downgraded Merck (NYSE: MRK) from Overweight to Equalweight.
For an analyst ratings summary and ratings history on Merck click here. For more ratings news on Merck click here.
Shares of Merck closed at $57.11 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo Double Downgrades Adobe (ADBE) to Underweight, 'more cautious on front office + creative'
- Deutsche Bank Downgrades C.H. Robinson Worldwide (CHRW) to Hold
- Merck (MRK) Reiterated at Neutral by Cantor Fitzgerald
Create E-mail Alert Related Categories
Downgrades, Hot DowngradesRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
